This policy paper, initiated and funded by AstraZeneca and developed in collaboration with a multidisciplinary group of academics, clinicians, patient advocates, and cancer policy… Read More
39 stakeholders call on EU HTA Coordination Group to adopt fit-for-purpose JCA methodology for ATMPs, recognising single-arm trials and real-world evidence. Read More
EAU, WFIPP, ICS, and CPE call on the European Commission to include incontinence as a co-morbidity in the EU Mental Health Strategy and fund research. Read More
CPE, MEPs, and researchers call on EU policymakers to harness Real-World Evidence to improve health outcomes, regulatory decisions, and access to medicines.
Read More
PCE and CPE’s February 2023 webinar report examines opportunities and challenges of the EU HTA Regulation with EC, MEPs, ESMO, EFPIA, and patient advocates. Read More
European health organisations including CPE issue recommendations on EHDS opt-out mechanism to protect research while ensuring data representativeness and equity. Read More
CPE’s July 2023 Brussels launch event brought together MEPs, OECD, and stakeholders to discuss Europe’s Beating Cancer Plan, HTA, and patient leadership. Read More
This Manifesto, led by the European Association of Urology and co-signed by Cancer Patients Europe and other stakeholders, addresses the continence health challenge affecting… Read More
This Press Release, jointly issued by 35 large European health stakeholder organisations including Cancer Patients Europe and representing patients, health professionals, researchers, and industry… Read More
PCE and partners’ position paper calls on the EU to tackle rising pancreatic cancer mortality through early detection, research funding, and equal treatment access. Read More